Luyan Pharma Co.,Ltd. (SHE:002788)

United States Steel Revenue

Luyan Pharma had revenue of 5.17B CNY in the quarter ending March 31, 2025, with 0.74% growth. This brings the company's revenue in the last twelve months to 20.51B, up 1.83% year-over-year. In the year 2024, Luyan Pharma had annual revenue of 20.47B with 3.15% growth.

• Revenue (ttm): 20.51B
• Revenue Growth: +1.83%
• P/S Ratio: 0.16
• Revenue / Employee: 3.66M
• Employees: 5,602
• Market Cap: 3.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	20.47B	625.23M	3.15%
Dec 31, 2023	19.85B	383.03M	1.97%
Jan 1, 2023	19.46B	1.92B	10.93%
Dec 31, 2021	17.55B	2.01B	12.94%
Dec 31, 2020	15.54B	526.42M	3.51%